Akari Therapeutics Plc Contracts & Agreements
33 Contracts & Agreements
- Business Finance (9 contracts)
- Business Operations (2)
- Human Resources (6)
- Mergers & Acquisitions (2)
- Uncategorized (14)
- Form of Securities Purchase Agreement, dated November 13, 2024, by and among Akari Therapeutics, Plc and the purchasers party thereto (Filed With SEC on November 14, 2024)
- Form of Series D Warrant (Filed With SEC on November 14, 2024)
- Amendment to Interim Chief Executive Officer Agreement, between Akari Therapeutics, Plc and Samir R. Patel, M.D., dated as of September 16, 2024 (Filed With SEC on September 18, 2024)
- Amendment to Interim Chief Executive Officer Agreement, dated as of September 13, 2024, by and between the Registrant and Samir Patel, M.D (Filed With SEC on September 13, 2024)
- Side Letter Agreement, dated August 15, 2024, by and among Akari Therapeutics, Plc, Pegasus Merger Sub, Inc. and Peak Bio, Inc (Filed With SEC on August 19, 2024)
- Form of Convertible Promissory Note, dated May 10, 2024, by and between Akari Therapeutics, Plc and the purchasers party thereto (Filed With SEC on August 19, 2024)
- Interim Chief Executive Officer Agreement, dated as of May 31, 2024, by and between the Company and Samir Patel, M.D (Filed With SEC on June 5, 2024)
- Form of Securities Purchase Agreement, dated May 29, 2024, by and among Akari Therapeutics, Plc and the purchasers party thereto (Filed With SEC on June 4, 2024)
- Form of Series C Warrant (Filed With SEC on June 4, 2024)
- Form of Placement Agent Warrant (Filed With SEC on June 4, 2024)
- Amendment No. 2 to Consulting Services Agreement, by and between the Company and Board Advantage LLC, dated April 26, 2024 (Filed With SEC on May 1, 2024)
- Stock Option Agreement between the Company and Rachelle Jacques dated March 28, 2023 (Filed With SEC on March 29, 2024)
- Stock Option Agreement between the Company and Wendy F. DiCicco dated July 17, 2023 (Filed With SEC on March 29, 2024)
- Consulting Agreement between the Company and Wendy F. DiCicco dated January 15, 2024 (Filed With SEC on March 29, 2024)
- Amendment No. 1 to Consulting Agreement between the Company and Wendy DiCicco dated September 1, 2023 (Filed With SEC on March 29, 2024)
- Consulting Agreement between the Company and Wendy DiCicco dated July 17, 2023 (Filed With SEC on March 29, 2024)
- Restricted Stock Unit Agreement between the Company and Rachelle Jacques dated June 1, 2023 (Filed With SEC on March 29, 2024)
- Form of Restricted Stock Unit Agreement Granted Under the 2023 Equity Incentive Plan (Filed With SEC on March 29, 2024)
- Form of ISO/NQ Stock Option Agreement Granted Under the 2023 Equity Incentive Plan (Filed With SEC on March 29, 2024)
- Description of the Akari Therapeutics Plc Securities Registered Under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 29, 2024)
- Form of Securities Purchase Agreement, dated March 11, 2024, by and among Akari Therapeutics, Plc and the purchasers party thereto (Filed With SEC on March 11, 2024)
- Form of Voting and Support Agreement, dated as of March 4, 2024, by and among Peak Bio and certain shareholders of Akari (Filed With SEC on March 5, 2024)
- Form of Voting and Support Agreement, dated as of March 4, 2024, by and among Akari, and certain stockholders of Peak Bio (Filed With SEC on March 5, 2024)
- Agreement and Plan of Merger, dated as of March 4, 2024, by and among Akari Therapeutics, Plc, Peak Bio, Inc. and Pegasus Merger Sub, Inc (Filed With SEC on March 5, 2024)
- AKARITHERAPEUTICS, PLC AMENDEDAND RESTATED NON-EMPLOYEEDIRECTOR COMPENSATION POLICY (Effectiveas of June 1, 2016) (Filed With SEC on June 30, 2016)
- AKARI THERAPEUTICS, PLC AMENDEDAND RESTATED NON-EMPLOYEEDIRECTOR COMPENSATION POLICY (Effectiveas of November 19, 2015) (Filed With SEC on November 25, 2015)
- AKARI THERAPEUTICS PLC and Clive richardson (Filed With SEC on September 22, 2015)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on September 22, 2015)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on September 22, 2015)
- REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on August 18, 2015)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 18, 2015)
- Schedule 12 (Filed With SEC on July 13, 2015)
- EXHIBIT A Confidentiality, Intellectual Property, Non-Competitionand Non-Solicitation Agreement (Filed With SEC on May 1, 2015)
